Growth Metrics

Gentex (GNTX) Cash & Equivalents (2016 - 2025)

Gentex's Cash & Equivalents history spans 17 years, with the latest figure at $145.6 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 37.58% year-over-year to $145.6 million; the TTM value through Dec 2025 reached $145.6 million, down 37.58%, while the annual FY2025 figure was $145.6 million, 37.58% down from the prior year.
  • Cash & Equivalents reached $145.6 million in Q4 2025 per GNTX's latest filing, down from $178.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $455.9 million in Q1 2021 to a low of $119.8 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $246.0 million, with a median of $243.3 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 63.7% in 2021, then tumbled 53.98% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $262.3 million in 2021, then dropped by 18.13% to $214.8 million in 2022, then increased by 5.44% to $226.4 million in 2023, then grew by 3.04% to $233.3 million in 2024, then plummeted by 37.58% to $145.6 million in 2025.
  • Per Business Quant, the three most recent readings for GNTX's Cash & Equivalents are $145.6 million (Q4 2025), $178.6 million (Q3 2025), and $119.8 million (Q2 2025).